CASI Pharmaceuticals logo

CASI Pharmaceuticals

North America, Maryland, United States, Rockville

Description

CASI focus on building a pipeline through mutually beneficial business development transactions.

Investor Profile

CASI Pharmaceuticals has backed more than 2 startups, with 0 new investments in the last 12 months alone. The firm has led 1 rounds, about 50% of its total and boasts 0 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series A, Series Unknown rounds (top funding stages).
  • Majority of deals are located in China.
  • Strong thematic focus on Health Care, Biotechnology, Pharmaceutical.

Stage Focus

  • Series A (50%)
  • Series Unknown (50%)

Country Focus

  • China (100%)

Industry Focus

  • Health Care
  • Biotechnology
  • Pharmaceutical
  • Medical
  • Therapeutics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does CASI Pharmaceuticals frequently co-invest with?

Dalton Venture
Asia, Shanghai, China, Shanghai
Co-Investments: 1
Redhill Capital
Asia, Guangdong, China, Guangzhou
Co-Investments: 1
Panacea Venture
North America, Midland, Cayman Islands, Grand Cayman
Co-Investments: 1
Emerging Technology Partners
North America, California, United States, San Francisco
Co-Investments: 1

What are some of recent deals done by CASI Pharmaceuticals?

Precision Autoimmune Therapeutics

Beijing, Beijing, China

Precision Autoimmune Therapeutics is a clinical stage innovative drug development company.

Health CareMedicalTherapeutics
Series UnknownJul 8, 2022
Amount Raised: $20,910,503
Juventas

Chaoyang, Liaoning, China

Juventas is a provider and developer of innovative immune cell therapeutic drugs.

BiotechnologyHealth CarePharmaceutical
Series AJul 9, 2019
Amount Raised: $14,515,473